Anderson-Fabry disease: recommendations for its diagnosis, management and treatment in South Africa, 2014 Article Swipe
Louisa Bhengu
,
Paul du Toit
,
B Henderson
,
K. Govendrageloo
,
René Heitner
,
L Mubaiwa
,
S Varughese
·
YOU?
·
· 2015
· Open Access
·
YOU?
·
· 2015
· Open Access
·
Background: Anderson-Fabry disease (AFD) is a rare, X-linked lysosomal storage disorder that leads to the accumulation of globotriasylceramide in the lysosomes in tissues throughout the body. The responsible gene is α-galactosidase A, found at chromosome Xq22. More than 400 mutations have been identified. The disease usually presents in childhood, is progressive and multisystem, and results in increasing disability and premature death. Objective: The objectives of these guidelines are to provide a standard of care for patients with AFD that is in keeping with that internationally, but which is also realistic for South Africa, and to provide a shared-care model for treating physicians and funders with regard to various aspects of care for these patients. Recommendations: All heathcare professionals involved in the diagnosis and management of AFD should take note of these guidelines and try to implement them in clinical practice as far as possible. Validation: These guidelines were developed through general consensus by the Lysosomal Storage Disorder Medical Advisory Board, and are largely based on the UK 2005 national guidelines for AFD, but have also been updated to include new treatment recommendations for enzyme replacement therapy based on evidence from subsequent publications. Conclusion: It is the intention that these guidelines will benefit all patients suffering from AFD disease, and enable them
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- http://sashg.org/documents/fabry-disease-guidelines.pdf
- OA Status
- green
- References
- 24
- Related Works
- 20
- OpenAlex ID
- https://openalex.org/W2171523302
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2171523302Canonical identifier for this work in OpenAlex
- Title
-
Anderson-Fabry disease: recommendations for its diagnosis, management and treatment in South Africa, 2014Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2015Year of publication
- Publication date
-
2015-01-28Full publication date if available
- Authors
-
Louisa Bhengu, Paul du Toit, B Henderson, K. Govendrageloo, René Heitner, L Mubaiwa, S VarugheseList of authors in order
- Landing page
-
https://sashg.org/documents/fabry-disease-guidelines.pdfPublisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
greenOpen access status per OpenAlex
- OA URL
-
https://sashg.org/documents/fabry-disease-guidelines.pdfDirect OA link when available
- Concepts
-
Medicine, Enzyme replacement therapy, Fabry disease, Disease, Lysosomal storage disease, Family medicine, Pediatrics, Intensive care medicine, PathologyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
24Number of works referenced by this work
- Related works (count)
-
20Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2171523302 |
|---|---|
| doi | |
| ids.mag | 2171523302 |
| ids.openalex | https://openalex.org/W2171523302 |
| fwci | 0.0 |
| type | article |
| title | Anderson-Fabry disease: recommendations for its diagnosis, management and treatment in South Africa, 2014 |
| biblio.issue | 1 |
| biblio.volume | 20 |
| biblio.last_page | 23 |
| biblio.first_page | 15 |
| topics[0].id | https://openalex.org/T10945 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2737 |
| topics[0].subfield.display_name | Physiology |
| topics[0].display_name | Lysosomal Storage Disorders Research |
| topics[1].id | https://openalex.org/T12604 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9916999936103821 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2745 |
| topics[1].subfield.display_name | Rheumatology |
| topics[1].display_name | Glycogen Storage Diseases and Myoclonus |
| topics[2].id | https://openalex.org/T10890 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.989799976348877 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2713 |
| topics[2].subfield.display_name | Epidemiology |
| topics[2].display_name | Trypanosoma species research and implications |
| is_xpac | False |
| apc_list.value | 5732 |
| apc_list.currency | ZAR |
| apc_list.value_usd | 311 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.9143671989440918 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2779969927 |
| concepts[1].level | 3 |
| concepts[1].score | 0.7561228275299072 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q916766 |
| concepts[1].display_name | Enzyme replacement therapy |
| concepts[2].id | https://openalex.org/C2777404818 |
| concepts[2].level | 3 |
| concepts[2].score | 0.7224625945091248 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q615645 |
| concepts[2].display_name | Fabry disease |
| concepts[3].id | https://openalex.org/C2779134260 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5990064740180969 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q12136 |
| concepts[3].display_name | Disease |
| concepts[4].id | https://openalex.org/C2778264360 |
| concepts[4].level | 3 |
| concepts[4].score | 0.44870391488075256 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q675010 |
| concepts[4].display_name | Lysosomal storage disease |
| concepts[5].id | https://openalex.org/C512399662 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4266071021556854 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q3505712 |
| concepts[5].display_name | Family medicine |
| concepts[6].id | https://openalex.org/C187212893 |
| concepts[6].level | 1 |
| concepts[6].score | 0.38687270879745483 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q123028 |
| concepts[6].display_name | Pediatrics |
| concepts[7].id | https://openalex.org/C177713679 |
| concepts[7].level | 1 |
| concepts[7].score | 0.3619915843009949 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q679690 |
| concepts[7].display_name | Intensive care medicine |
| concepts[8].id | https://openalex.org/C142724271 |
| concepts[8].level | 1 |
| concepts[8].score | 0.30653172731399536 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[8].display_name | Pathology |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.9143671989440918 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/enzyme-replacement-therapy |
| keywords[1].score | 0.7561228275299072 |
| keywords[1].display_name | Enzyme replacement therapy |
| keywords[2].id | https://openalex.org/keywords/fabry-disease |
| keywords[2].score | 0.7224625945091248 |
| keywords[2].display_name | Fabry disease |
| keywords[3].id | https://openalex.org/keywords/disease |
| keywords[3].score | 0.5990064740180969 |
| keywords[3].display_name | Disease |
| keywords[4].id | https://openalex.org/keywords/lysosomal-storage-disease |
| keywords[4].score | 0.44870391488075256 |
| keywords[4].display_name | Lysosomal storage disease |
| keywords[5].id | https://openalex.org/keywords/family-medicine |
| keywords[5].score | 0.4266071021556854 |
| keywords[5].display_name | Family medicine |
| keywords[6].id | https://openalex.org/keywords/pediatrics |
| keywords[6].score | 0.38687270879745483 |
| keywords[6].display_name | Pediatrics |
| keywords[7].id | https://openalex.org/keywords/intensive-care-medicine |
| keywords[7].score | 0.3619915843009949 |
| keywords[7].display_name | Intensive care medicine |
| keywords[8].id | https://openalex.org/keywords/pathology |
| keywords[8].score | 0.30653172731399536 |
| keywords[8].display_name | Pathology |
| language | en |
| locations[0].id | mag:2171523302 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S147026946 |
| locations[0].source.issn | 0256-9574, 2078-5135 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 0256-9574 |
| locations[0].source.is_core | False |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | South African Medical Journal |
| locations[0].source.host_organization | https://openalex.org/P4310315351 |
| locations[0].source.host_organization_name | Health and Medical Publishing Group |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310315351 |
| locations[0].source.host_organization_lineage_names | Health and Medical Publishing Group |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | |
| locations[0].raw_type | |
| locations[0].license_id | |
| locations[0].is_accepted | False |
| locations[0].is_published | |
| locations[0].raw_source_name | South African Medical Journal |
| locations[0].landing_page_url | http://sashg.org/documents/fabry-disease-guidelines.pdf |
| authorships[0].author.id | https://openalex.org/A5046323222 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Louisa Bhengu |
| authorships[0].countries | ZA |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I192619145 |
| authorships[0].affiliations[0].raw_affiliation_string | university of the witwatersrand |
| authorships[0].institutions[0].id | https://openalex.org/I192619145 |
| authorships[0].institutions[0].ror | https://ror.org/03rp50x72 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I192619145 |
| authorships[0].institutions[0].country_code | ZA |
| authorships[0].institutions[0].display_name | University of the Witwatersrand |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Bhengu L |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | university of the witwatersrand |
| authorships[1].author.id | https://openalex.org/A5110537059 |
| authorships[1].author.orcid | |
| authorships[1].author.display_name | Paul du Toit |
| authorships[1].countries | ZA |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I157614274 |
| authorships[1].affiliations[0].raw_affiliation_string | University of Cape Town |
| authorships[1].institutions[0].id | https://openalex.org/I157614274 |
| authorships[1].institutions[0].ror | https://ror.org/03p74gp79 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I157614274 |
| authorships[1].institutions[0].country_code | ZA |
| authorships[1].institutions[0].display_name | University of Cape Town |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Toit P |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | University of Cape Town |
| authorships[2].author.id | https://openalex.org/A5065753537 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | B Henderson |
| authorships[2].countries | ZA |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I26999989 |
| authorships[2].affiliations[0].raw_affiliation_string | University Of The Free State |
| authorships[2].institutions[0].id | https://openalex.org/I26999989 |
| authorships[2].institutions[0].ror | https://ror.org/009xwd568 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I26999989 |
| authorships[2].institutions[0].country_code | ZA |
| authorships[2].institutions[0].display_name | University of the Free State |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Henderson B |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | University Of The Free State |
| authorships[3].author.id | https://openalex.org/A5110008197 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | K. Govendrageloo |
| authorships[3].countries | ZA |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I95023434 |
| authorships[3].affiliations[0].raw_affiliation_string | University of KwaZulu/Natal |
| authorships[3].institutions[0].id | https://openalex.org/I95023434 |
| authorships[3].institutions[0].ror | https://ror.org/04qzfn040 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I95023434 |
| authorships[3].institutions[0].country_code | ZA |
| authorships[3].institutions[0].display_name | University of KwaZulu-Natal |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Govendrageloo K |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | University of KwaZulu/Natal |
| authorships[4].author.id | https://openalex.org/A5049636476 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | René Heitner |
| authorships[4].countries | ZA |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I192619145 |
| authorships[4].affiliations[0].raw_affiliation_string | university of the witwatersrand |
| authorships[4].institutions[0].id | https://openalex.org/I192619145 |
| authorships[4].institutions[0].ror | https://ror.org/03rp50x72 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I192619145 |
| authorships[4].institutions[0].country_code | ZA |
| authorships[4].institutions[0].display_name | University of the Witwatersrand |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Heitner R |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | university of the witwatersrand |
| authorships[5].author.id | https://openalex.org/A5000851802 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | L Mubaiwa |
| authorships[5].countries | ZA |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I95023434 |
| authorships[5].affiliations[0].raw_affiliation_string | University of KwaZulu/Natal |
| authorships[5].institutions[0].id | https://openalex.org/I95023434 |
| authorships[5].institutions[0].ror | https://ror.org/04qzfn040 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I95023434 |
| authorships[5].institutions[0].country_code | ZA |
| authorships[5].institutions[0].display_name | University of KwaZulu-Natal |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Mubaiwa L |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | University of KwaZulu/Natal |
| authorships[6].author.id | https://openalex.org/A5112736990 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | S Varughese |
| authorships[6].countries | ZA |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I192619145 |
| authorships[6].affiliations[0].raw_affiliation_string | university of the witwatersrand |
| authorships[6].institutions[0].id | https://openalex.org/I192619145 |
| authorships[6].institutions[0].ror | https://ror.org/03rp50x72 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I192619145 |
| authorships[6].institutions[0].country_code | ZA |
| authorships[6].institutions[0].display_name | University of the Witwatersrand |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Varughese S |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | university of the witwatersrand |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | http://sashg.org/documents/fabry-disease-guidelines.pdf |
| open_access.oa_status | green |
| open_access.any_repository_has_fulltext | False |
| created_date | 2016-06-24T00:00:00 |
| display_name | Anderson-Fabry disease: recommendations for its diagnosis, management and treatment in South Africa, 2014 |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-10-10T17:16:08.811792 |
| primary_topic.id | https://openalex.org/T10945 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2737 |
| primary_topic.subfield.display_name | Physiology |
| primary_topic.display_name | Lysosomal Storage Disorders Research |
| related_works | https://openalex.org/W2095226396, https://openalex.org/W2265997400, https://openalex.org/W2808184073, https://openalex.org/W2792992167, https://openalex.org/W3152127110, https://openalex.org/W2162222437, https://openalex.org/W2158778040, https://openalex.org/W1918265621, https://openalex.org/W2158211413, https://openalex.org/W2046617178, https://openalex.org/W2141880469, https://openalex.org/W2893934812, https://openalex.org/W3127389350, https://openalex.org/W2147904319, https://openalex.org/W2001733646, https://openalex.org/W2096261757, https://openalex.org/W2397692523, https://openalex.org/W2048934331, https://openalex.org/W1996107840, https://openalex.org/W1981685638 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | mag:2171523302 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S147026946 |
| best_oa_location.source.issn | 0256-9574, 2078-5135 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 0256-9574 |
| best_oa_location.source.is_core | False |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | South African Medical Journal |
| best_oa_location.source.host_organization | https://openalex.org/P4310315351 |
| best_oa_location.source.host_organization_name | Health and Medical Publishing Group |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310315351 |
| best_oa_location.source.host_organization_lineage_names | Health and Medical Publishing Group |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | |
| best_oa_location.raw_type | |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | False |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | South African Medical Journal |
| best_oa_location.landing_page_url | http://sashg.org/documents/fabry-disease-guidelines.pdf |
| primary_location.id | mag:2171523302 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S147026946 |
| primary_location.source.issn | 0256-9574, 2078-5135 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 0256-9574 |
| primary_location.source.is_core | False |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | South African Medical Journal |
| primary_location.source.host_organization | https://openalex.org/P4310315351 |
| primary_location.source.host_organization_name | Health and Medical Publishing Group |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310315351 |
| primary_location.source.host_organization_lineage_names | Health and Medical Publishing Group |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | |
| primary_location.raw_type | |
| primary_location.license_id | |
| primary_location.is_accepted | False |
| primary_location.is_published | False |
| primary_location.raw_source_name | South African Medical Journal |
| primary_location.landing_page_url | http://sashg.org/documents/fabry-disease-guidelines.pdf |
| publication_date | 2015-01-28 |
| publication_year | 2015 |
| referenced_works | https://openalex.org/W2099728000, https://openalex.org/W1991603736, https://openalex.org/W2005201918, https://openalex.org/W2313827278, https://openalex.org/W2093722439, https://openalex.org/W2150885355, https://openalex.org/W2125879510, https://openalex.org/W2154062927, https://openalex.org/W2127986324, https://openalex.org/W2159335384, https://openalex.org/W2071598008, https://openalex.org/W1993455435, https://openalex.org/W2128419115, https://openalex.org/W1790440725, https://openalex.org/W2001951305, https://openalex.org/W2040818909, https://openalex.org/W1987120501, https://openalex.org/W2022356406, https://openalex.org/W1973024013, https://openalex.org/W2023001129, https://openalex.org/W2139927163, https://openalex.org/W2073058993, https://openalex.org/W2094355363, https://openalex.org/W2069483072 |
| referenced_works_count | 24 |
| abstract_inverted_index.a | 5, 70, 96 |
| abstract_inverted_index.A, | 31 |
| abstract_inverted_index.It | 193 |
| abstract_inverted_index.UK | 166 |
| abstract_inverted_index.as | 140, 142 |
| abstract_inverted_index.at | 33 |
| abstract_inverted_index.by | 152 |
| abstract_inverted_index.in | 18, 21, 47, 55, 80, 119, 137 |
| abstract_inverted_index.is | 4, 29, 49, 79, 87, 194 |
| abstract_inverted_index.of | 16, 64, 72, 109, 124, 129 |
| abstract_inverted_index.on | 164, 187 |
| abstract_inverted_index.to | 13, 68, 94, 106, 134, 177 |
| abstract_inverted_index.400 | 38 |
| abstract_inverted_index.AFD | 77, 125, 206 |
| abstract_inverted_index.All | 115 |
| abstract_inverted_index.The | 26, 43, 62 |
| abstract_inverted_index.all | 202 |
| abstract_inverted_index.and | 51, 53, 58, 93, 102, 122, 132, 160, 208 |
| abstract_inverted_index.are | 67, 161 |
| abstract_inverted_index.but | 85, 172 |
| abstract_inverted_index.far | 141 |
| abstract_inverted_index.for | 74, 90, 99, 111, 170, 182 |
| abstract_inverted_index.new | 179 |
| abstract_inverted_index.the | 14, 19, 24, 120, 153, 165, 195 |
| abstract_inverted_index.try | 133 |
| abstract_inverted_index.2005 | 167 |
| abstract_inverted_index.AFD, | 171 |
| abstract_inverted_index.More | 36 |
| abstract_inverted_index.also | 88, 174 |
| abstract_inverted_index.been | 41, 175 |
| abstract_inverted_index.care | 73, 110 |
| abstract_inverted_index.from | 189, 205 |
| abstract_inverted_index.gene | 28 |
| abstract_inverted_index.have | 40, 173 |
| abstract_inverted_index.note | 128 |
| abstract_inverted_index.take | 127 |
| abstract_inverted_index.than | 37 |
| abstract_inverted_index.that | 11, 78, 83, 197 |
| abstract_inverted_index.them | 136, 210 |
| abstract_inverted_index.were | 147 |
| abstract_inverted_index.will | 200 |
| abstract_inverted_index.with | 76, 82, 104 |
| abstract_inverted_index.(AFD) | 3 |
| abstract_inverted_index.South | 91 |
| abstract_inverted_index.These | 145 |
| abstract_inverted_index.Xq22. | 35 |
| abstract_inverted_index.based | 163, 186 |
| abstract_inverted_index.body. | 25 |
| abstract_inverted_index.found | 32 |
| abstract_inverted_index.leads | 12 |
| abstract_inverted_index.model | 98 |
| abstract_inverted_index.rare, | 6 |
| abstract_inverted_index.these | 65, 112, 130, 198 |
| abstract_inverted_index.which | 86 |
| abstract_inverted_index.Board, | 159 |
| abstract_inverted_index.death. | 60 |
| abstract_inverted_index.enable | 209 |
| abstract_inverted_index.enzyme | 183 |
| abstract_inverted_index.regard | 105 |
| abstract_inverted_index.should | 126 |
| abstract_inverted_index.Africa, | 92 |
| abstract_inverted_index.Medical | 157 |
| abstract_inverted_index.Storage | 155 |
| abstract_inverted_index.aspects | 108 |
| abstract_inverted_index.benefit | 201 |
| abstract_inverted_index.disease | 2, 44 |
| abstract_inverted_index.funders | 103 |
| abstract_inverted_index.general | 150 |
| abstract_inverted_index.include | 178 |
| abstract_inverted_index.keeping | 81 |
| abstract_inverted_index.largely | 162 |
| abstract_inverted_index.provide | 69, 95 |
| abstract_inverted_index.results | 54 |
| abstract_inverted_index.storage | 9 |
| abstract_inverted_index.therapy | 185 |
| abstract_inverted_index.through | 149 |
| abstract_inverted_index.tissues | 22 |
| abstract_inverted_index.updated | 176 |
| abstract_inverted_index.usually | 45 |
| abstract_inverted_index.various | 107 |
| abstract_inverted_index.Advisory | 158 |
| abstract_inverted_index.Disorder | 156 |
| abstract_inverted_index.X-linked | 7 |
| abstract_inverted_index.clinical | 138 |
| abstract_inverted_index.disease, | 207 |
| abstract_inverted_index.disorder | 10 |
| abstract_inverted_index.evidence | 188 |
| abstract_inverted_index.involved | 118 |
| abstract_inverted_index.national | 168 |
| abstract_inverted_index.patients | 75, 203 |
| abstract_inverted_index.practice | 139 |
| abstract_inverted_index.presents | 46 |
| abstract_inverted_index.standard | 71 |
| abstract_inverted_index.treating | 100 |
| abstract_inverted_index.Lysosomal | 154 |
| abstract_inverted_index.consensus | 151 |
| abstract_inverted_index.developed | 148 |
| abstract_inverted_index.diagnosis | 121 |
| abstract_inverted_index.heathcare | 116 |
| abstract_inverted_index.implement | 135 |
| abstract_inverted_index.intention | 196 |
| abstract_inverted_index.lysosomal | 8 |
| abstract_inverted_index.lysosomes | 20 |
| abstract_inverted_index.mutations | 39 |
| abstract_inverted_index.patients. | 113 |
| abstract_inverted_index.possible. | 143 |
| abstract_inverted_index.premature | 59 |
| abstract_inverted_index.realistic | 89 |
| abstract_inverted_index.suffering | 204 |
| abstract_inverted_index.treatment | 180 |
| abstract_inverted_index.Objective: | 61 |
| abstract_inverted_index.childhood, | 48 |
| abstract_inverted_index.chromosome | 34 |
| abstract_inverted_index.disability | 57 |
| abstract_inverted_index.guidelines | 66, 131, 146, 169, 199 |
| abstract_inverted_index.increasing | 56 |
| abstract_inverted_index.management | 123 |
| abstract_inverted_index.objectives | 63 |
| abstract_inverted_index.physicians | 101 |
| abstract_inverted_index.subsequent | 190 |
| abstract_inverted_index.throughout | 23 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.Conclusion: | 192 |
| abstract_inverted_index.Validation: | 144 |
| abstract_inverted_index.identified. | 42 |
| abstract_inverted_index.progressive | 50 |
| abstract_inverted_index.replacement | 184 |
| abstract_inverted_index.responsible | 27 |
| abstract_inverted_index.shared-care | 97 |
| abstract_inverted_index.accumulation | 15 |
| abstract_inverted_index.multisystem, | 52 |
| abstract_inverted_index.professionals | 117 |
| abstract_inverted_index.publications. | 191 |
| abstract_inverted_index.Anderson-Fabry | 1 |
| abstract_inverted_index.recommendations | 181 |
| abstract_inverted_index.Recommendations: | 114 |
| abstract_inverted_index.internationally, | 84 |
| abstract_inverted_index.α-galactosidase | 30 |
| abstract_inverted_index.globotriasylceramide | 17 |
| cited_by_percentile_year | |
| countries_distinct_count | 1 |
| institutions_distinct_count | 7 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.6200000047683716 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.08619942 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |